Recent advances in adherence and invasion of pathogenic Escherichia coli

Current Opinion in Infectious Diseases

Volumn 27, Issue 5, 2014, Pages 459-464

  Kalita, Anjana ^a   Hu, Jia ^a   Torres, Alfredo G ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

adherent invasive Escherichia coli; enteroaggregative; enterohemorrhagic Escherichia coli; enteropathogenic; enterotoxigenic; uropathogenic

Indexed keywords

ADHESIN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; ENTEROTOXIN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; INVASIN; MUCIN 3; SHIGA TOXIN; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; UROPLAKIN; VIRULENCE FACTOR; SCLEROPROTEIN;

BACTERIAL COLONIZATION; BACTERIAL INVASION; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CROHN DISEASE; ENTEROAGGREGATIVE ESCHERICHIA COLI; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI O157; HEMOLYTIC UREMIC SYNDROME; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; INTESTINE; INTESTINE FLORA; MENINX; NONHUMAN; NUTRIENT AVAILABILITY; PATHOGENESIS; PATHOGENIC ESCHERICHIA COLI; PHYLOGENY; REVIEW; TYPE III SECRETION SYSTEM; URINARY TRACT; UROPATHOGENIC ESCHERICHIA COLI; ANIMAL; BACTERIAL MENINGITIS; BACTERIAL TRANSLOCATION; BLOOD BRAIN BARRIER; COMPLICATION; DISEASE MODEL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; HOST PATHOGEN INTERACTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOUSE; PATHOGENICITY; URINARY TRACT INFECTIONS; VASCULAR ENDOTHELIUM;

ADHESINS, ESCHERICHIA COLI; ANIMALS; BACTERIAL ADHESION; BACTERIAL TRANSLOCATION; BLOOD-BRAIN BARRIER; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; EXTRACELLULAR MATRIX PROTEINS; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; MENINGITIS, ESCHERICHIA COLI; MICE; URINARY TRACT INFECTIONS;

EID: 84906936433     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000092     Document Type: Review

References (61)

1. Leimbach A, Hacker J, Dobrindt U. E. coli as an all-rounder: the thin line between commensalism and pathogenicity. Curr Top Microbiol Immunol 2013; 358:3-32.
2. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nature Rev Microbiol 2004; 2:123-140.
3. Croxen MA, Law RJ, Scholz R, et al. Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev 2013; 4:822-880.
4. Farfan MJ, Torres AG. Molecular mechanisms that mediate colonization of Shiga toxin-producing Escherichia coli strains. Infect Immun 2012; 80:903-913.
5. Ferens WA, Hovde CJ. Escherichia coli O157:H7: animal reservoir and sources of human infection. Foodborne Pathog Dis 2011; 8:465-487.
6. Zumbrun SD, Melton-Celsa AR, Smith MA, et al. Dietary choice affects Shiga toxin-producing Escherichia coli (STEC) O157:H7 colonization and disease. Proc Natl Acad Sci USA 2013; 110:E2126-E2133.
7. Sheng H, Nguyen YN, Hovde CJ, Sperandio V. SdiA aids enterohemorrhagic Escherichia coli carriage by cattle fed a forage or grain diet. Infect Immun 2013; 81:3472-3478.
8. Hughes DT, Terekhova DA, Liou L, et al. Chemical sensing in mammalian hostbacterial commensal associations. Proc Natl Acad Sci USA 2010; 107:9831-9836.
9. Garlanda C, Riva F, Polentarutti N, et al. Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. Proc Natl Acad Sci USA 2004; 101:3522-3526.
10. Wald D, Qin J, Zhao Z, et al. SIGIRR, a negative regulator of Toll-like receptorinterleukin 1 receptor signaling. Nat Immunol 2003; 4:920-927.
11. Sham HP, Yu EY, Gulen MF, et al. SIGIRR, a negative regulator of TLR/IL-1R signalling promotes microbiota dependent resistance to colonization by enteric bacterial pathogens. PLoS Pathog 2013; 9:e1003539.
12. Hansen AM, Chaerkady R, Sharma J, et al. The Escherichia coli phosphotyrosine proteome relates to core pathways and virulence. PLoS Pathog 2013; 9:e1003403.
13. Hansen AM, Jin DJ. SspA up-regulates gene expression of the LEE pathogenicity island by decreasing H-NS levels in enterohemorrhagic Escherichia coli. BMC Microbiol 2012; 12:231.
14. Branchu P, Matrat S, Vareille M, et al. NsrR, GadE, and GadX interplay in repressing expression of the Escherichia coli O157:H7 LEE pathogenicity island in response to nitric oxide. PLoS Pathog 2014; 10:e1003874.
15. Ochoa TJ, Barletta F, Contreras C, Mercado E. New insights into the epidemiology of enteropathogenic Escherichia coli infection. Trans R Soc Trop Med Hyg 2008; 102:852-856.
16. Enserink R, Scholts R, Bruijning-Verhagen P, et al. High detection rates of enteropathogens in asymptomatic children attending day care. PLoS One 2014; 9:e89496.
17. Yatsuyanagi J, Saito S, Sato H, et al. Characterization of enteropathogenic and enteroaggregative Escherichia coli isolated from diarrheal outbreaks. J Clin Microbiol 2002; 40:294-297.
18. Hernandes RT, Elias WP, Vieira MA, Gomes TA. An overview of atypical enteropathogenic Escherichia coli. FEMS Microbiol Lett 2009; 297:137-149.
19. Hernandes RT, De la Cruz MA, Yamamoto D, et al. Dissection of the role of pili and type 2 and 3 secretion systems in adherence and biofilm formation of an atypical enteropathogenic Escherichia coli strain. Infect Immun 2013; 81:3793-3802.
20. Kelly M, Hart E, Mundy R, et al. Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. Infect Immun 2006; 74:2328-2337.
21. Newton HJ, Pearson JS, Badea L, et al. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog 2010; 6:e1000898.
22. Gao X, Wang X, Pham TH, et al. NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-kappaB activation. Cell Host Microbe 2013; 13:87-99.
23. Pearson JS, Giogha C, Ong SY, et al. A type III effector antagonizes death receptor signalling during bacterial gut infection. Nature 2013; 501:247-251.
24. Li S, Zhang L, Yao Q, et al. Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains. Nature 2013; 501:242-246.
25. Pan Q, Tian Y, Li X, et al. Enhanced membrane-tethered mucin 3 (MUC3) expression by a tetrameric branched peptide with a conserved TFLK motif inhibits bacteria adherence. J Biol Chem 2013; 288:5407-5416.
26. Salcedo J, Barbera R, Matencio E, et al. Gangliosides and sialic acid effects upon newborn pathogenic bacteria adhesion: an in vitro study. Food Chem 2013; 136:726-734.
27. Beatty ME, Adcock PM, Smith SW, et al. Epidemic diarrhea due to enterotoxigenic Escherichia coli. Clin Infect Dis 2006; 42:329-334.
28. Torres AG, Zhou X, Kaper JB. Adherence of diarrheagenic Escherichia coli strains to epithelial cells. Infect Immun 2005; 73:18-29.
29. Guevara CP, Luiz WB, Sierra A, et al. Enterotoxigenic Escherichia coli CS21 pilus contributes to adhesion to intestinal cells and to pathogenesis under in vivo conditions. Microbiology 2013; 159:1725-1735.
30. Fekete PZ, Mateo KS, Zhang W, et al. Both enzymatic and nonenzymatic properties of heat-labile enterotoxin are responsible for LT-enhanced adherence of enterotoxigenic Escherichia coli to porcine IPEC-J2 cells. Vet Microbiol 2013; 164:330-335.
31. Kansal R, Rasko DA, Sahl JW, et al. Transcriptional modulation of enterotoxigenic Escherichia coli virulence genes in response to epithelial cell interactions. Infect Immun 2013; 81:259-270.
32. Zhou M, Duan Q, Zhu X, et al. Both flagella and F4 fimbriae from F4ac\+ enterotoxigenic Escherichia coli contribute to attachment to IPEC-J2 cells in vitro. Vet Res 2013; 44:30.
33. Gonzalez-Ortiz G, Perez JF, Hermes RG, et al. Screening the ability of natural feed ingredients to interfere with the adherence of enterotoxigenic Escherichia coli (ETEC) K88 to the porcine intestinal mucus. Br J Nutr 2014; 111:633-642.
34. Roberts CL, Keita AV, Parsons BN, et al. Soluble plantain fibre blocks adhesion and M-cell translocation of intestinal pathogens. J Nutr Biochem 2013; 24:97-103.
35. Flores J, Okhuysen PC. Enteroaggregative Escherichia coli infection. Curr Opin Gastroenterol 2009; 25:8-11.
36. Weintraub A. Enteroaggregative Escherichia coli: epidemiology, virulence and detection. J Med Microbiol 2007; 56:4-8.
37. Lima IF, Boisen N, Quetz Jda S, et al. Prevalence of enteroaggregative Escherichia coli and its virulence-related genes in a case-control study among children from north-eastern Brazil. J Med Microbiol 2013; 62:683-693.
38. Nuesch-Inderbinen MT, Hofer E, Hachler H, et al. Characteristics of enteroaggregative Escherichia coli isolated from healthy carriers and from patients with diarrhoea. J Med Microbiol 2013; 62:1828-1834.
39. Munera D, Ritchie JM, Hatzios SK, et al. Autotransporters but not pAA are critical for rabbit colonization by Shiga toxin-producing Escherichia coli O104:H4. Nat Commun 2014; 5:3080.
40. Herzog K, Engeler Dusel J, Hugentobler M, et al. Diarrheagenic enteroaggregative Escherichia coli causing urinary tract infection and bacteremia leading to sepsis. Infection 2014; 42:441-444.
41. Boll EJ, Struve C, Boisen N, et al. Role of enteroaggregative Escherichia coli virulence factors in uropathogenesis. Infect Immun 2013; 81:1164-1171.
42. Jafari A, Shafaei E, Oloomi M, et al. Genotypic and phenotypic comparison of enteroaggregative Escherichia coli isolates from HIV-positive and non-HIV diarrheal samples. Curr HIV Res 2014; 11:635-641.
43. Cieza RJ, Cao AT, Cong Y, Torres AG. Immunomodulation for gastrointestinal infections. Expert Rev Anti Infect Ther 2012; 10:391-400.
44. Rolhion N, Darfeuille-Michaud A. Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis 2007; 13:1277-1283.
45. Glasser AL, Boudeau J, Barnich N, et al. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun 2001; 69: 5529-5537.
46. Small CL, Reid-Yu SA, McPhee JB, Coombes BK. Persistent infection with Crohn's disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis. Nat Commun 2013; 4:1957.
47. Glas J, Seiderer J, Fries C, et al. CEACAM6 gene variants in inflammatory bowel disease. PLoS One 2011; 6:e19319.
48. Barnich N, Carvalho FA, Glasser AL, et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 2007; 117:1566-1574.
49. Martinez-Medina M, Denizot J, Dreux N, et al. Western diet induces dysbiosis with increased E. coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation. Gut 2014; 63:116-124.
50. Dreux N, Denizot J, Martinez-Medina M, et al. Point mutations in FimH adhesin of Crohn's disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response. PLoS Pathog 2013; 9:e1003141.
51. Chassaing B, Rolhion N, de Vallee A, et al. Crohn disease: associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae. J Clin Invest 2011; 121:966-975.
52. Chassaing B, Etienne-Mesmin L, Bonnet R, Darfeuille-Michaud A. Bile salts induce long polar fimbriae expression favouring Crohn's disease-associated adherent-invasive Escherichia coli interaction with Peyer's patches. Environ Microbiol 2013; 15:355-371.
53. Chassaing B, Koren O, Carvalho FA, et al. AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition. Gut 2014; 63:1069-1080.
54. Cleynen I, Vazeille E, Artieda M, et al. Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease. Gut 2013; 62:1-10.
55. Sauer FG, Mulvey MA, Schilling JD, et al. Bacterial pili: molecular mechanisms of pathogenesis. Curr Opin Microbiol 2000; 3:65-72.
56. Schwartz DJ, Kalas V, Pinkner JS, et al. Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation. Proc Natl Acad Sci USA 2013; 110:15530-15537.
57. Anderson GG, Palermo JJ, Schilling JD, et al. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 2003; 301:105-107.
58. Mitra A, Palaniyandi S, Herren CD, et al. Pleiotropic roles of uvrY on biofilm formation, motility and virulence in uropathogenic Escherichia coli CFT073. PLoS One 2013; 8:e55492.
59. Debnath I, Norton JP, Barber AE, et al. The Cpx stress response system potentiates the fitness and virulence of uropathogenic Escherichia coli. Infect Immun 2013; 81:1450-1459.
60. Dorota W, Marta K, Dorota TG. Effect of asiatic and ursolic acids on morphology, hydrophobicity, and adhesion of UPECs to uroepithelial cells. Folia Microbiol (Praha) 2013; 58:245-252.
61. Rafsanjany N, Lechtenberg M, Petereit F, Hensel A. Antiadhesion as a functional concept for protection against uropathogenic Escherichia coli: in vitro studies with traditionally used plants with antiadhesive activity against uropathognic Escherichia coli. J Ethnopharmacol 2013; 145:591-597.